In addition, diabetes medications were also adjusted by diabetologists at the start and during the follow - up, and patients were fed less carbohydrates and exercised more - up to 300 minutes per week, he said. (joslin.org)
But even if it doesn't, that might not matter for developing an anti-obesity drug, says diabetologist Barry Goldstein of Thomas Jefferson University in Philadelphia: «The fact that the results are so clean, that there are apparently no other phenotypic changes, makes [PTP - 1B] a very exciting drug target.» (sciencemag.org)
The report is produced by a working group of 17 international health experts, including Professor Melanie Davies who is Professor of Diabetes Medicine at the University and an Honorary Consultant Diabetologist at the University Hospitals of Leicester NHS Trust, Leicester, UK. (www2.le.ac.uk)